Skip to main content
. 2021 Oct 8;39(3):367–372. doi: 10.1093/fampra/cmab116

Table 3.

Reported adverse reactions within 3 months after the CSI.

Adverse reaction No.
Local skin reaction 14
Hyperglycaemia 9
Abnormal menstruation 6
Flushing 5
Arrhythmia 4
Increased pain 4
Headaches 3
Cramps 2
Vertigo 1
Nausea 1

N = 968. Forty-three patients (4%) had reported adverse reactions. In 4 patients, more than 1 adverse reaction was reported.